enVVeno Medical Corporation (NVNO)
USD 2.48
(-4.25%)
USD 2.48
(-4.25%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 25.23 Million USD | 1.23% |
| 2022 | 24.93 Million USD | 47.59% |
| 2021 | 16.89 Million USD | 84.92% |
| 2020 | 9.13 Million USD | 28.34% |
| 2019 | 7.11 Million USD | -7.82% |
| 2018 | 7.72 Million USD | 26.47% |
| 2017 | 6.1 Million USD | 31.74% |
| 2016 | 4.63 Million USD | 259.33% |
| 2015 | 1.28 Million USD | 22.05% |
| 2014 | 1.05 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5.31 Million USD | -0.82% |
| 2024 Q1 | 5.36 Million USD | -12.73% |
| 2024 Q3 | 6.17 Million USD | 16.02% |
| 2023 Q2 | 6.81 Million USD | 0.25% |
| 2023 FY | 24.69 Million USD | -0.96% |
| 2023 Q1 | 6.79 Million USD | 5.22% |
| 2023 Q3 | 5.34 Million USD | -21.5% |
| 2023 Q4 | 6.14 Million USD | 14.86% |
| 2022 Q1 | 5.33 Million USD | -40.67% |
| 2022 FY | 24.93 Million USD | 47.59% |
| 2022 Q4 | 6.46 Million USD | 5.02% |
| 2022 Q3 | 6.15 Million USD | -11.95% |
| 2022 Q2 | 6.98 Million USD | 30.95% |
| 2021 FY | 16.89 Million USD | 84.92% |
| 2021 Q3 | 2.7 Million USD | 13.46% |
| 2021 Q2 | 2.38 Million USD | -15.06% |
| 2021 Q1 | 2.8 Million USD | -32.47% |
| 2021 Q4 | 8.99 Million USD | 232.24% |
| 2020 Q2 | 1.54 Million USD | 2.48% |
| 2020 Q4 | 4.15 Million USD | 116.33% |
| 2020 FY | 9.13 Million USD | 28.34% |
| 2020 Q1 | 1.5 Million USD | -11.79% |
| 2020 Q3 | 1.92 Million USD | 24.35% |
| 2019 Q4 | 1.71 Million USD | -6.75% |
| 2019 FY | 7.11 Million USD | -7.82% |
| 2019 Q3 | 1.83 Million USD | -6.42% |
| 2019 Q2 | 1.95 Million USD | 21.47% |
| 2019 Q1 | 1.61 Million USD | 6.88% |
| 2018 Q3 | 1.52 Million USD | -52.14% |
| 2018 Q4 | 1.5 Million USD | -1.28% |
| 2018 FY | 7.72 Million USD | 26.47% |
| 2018 Q1 | 1.48 Million USD | -25.84% |
| 2018 Q2 | 3.19 Million USD | 114.8% |
| 2017 Q3 | 1.7 Million USD | 34.36% |
| 2017 FY | 6.1 Million USD | 31.74% |
| 2017 Q1 | 1.12 Million USD | -8.65% |
| 2017 Q2 | 1.27 Million USD | 13.22% |
| 2017 Q4 | 2 Million USD | 17.5% |
| 2016 Q2 | 1.45 Million USD | 0.0% |
| 2016 Q3 | 958.82 Thousand USD | -34.32% |
| 2016 Q1 | 1.45 Million USD | 150.27% |
| 2016 Q4 | 1.22 Million USD | 28.12% |
| 2016 FY | 4.63 Million USD | 259.33% |
| 2015 Q4 | 583.33 Thousand USD | 0.0% |
| 2015 FY | 1.28 Million USD | 22.05% |
| 2014 FY | 1.05 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -124.857% |
| Cerus Corporation | 143.15 Million USD | 82.37% |
| OrthoPediatrics Corp. | 137.01 Million USD | 81.581% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -122.149% |
| Talis Biomedical Corporation | 67.18 Million USD | 62.436% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -1.171% |
| Inogen, Inc. | 236.08 Million USD | 89.31% |
| Spectral AI, Inc. | 20.86 Million USD | -20.964% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 54.93% |
| CVRx, Inc. | 76.14 Million USD | 66.854% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -615.364% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -102.082% |
| Orthofix Medical Inc. | 667.42 Million USD | 96.219% |
| Venus Concept Inc. | 80.47 Million USD | 68.639% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 55.393% |
| Bioventus Inc. | 409.91 Million USD | 93.843% |
| BrainsWay Ltd. | 28.01 Million USD | 9.922% |
| Envoy Medical, Inc. | 17.89 Million USD | -41.01% |
| electroCore, Inc. | 32.03 Million USD | 21.208% |
| IceCure Medical Ltd | 16.87 Million USD | -49.55% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 40.521% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -43.129% |
| MaxCyte, Inc. | 84.84 Million USD | 70.254% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -103.339% |
| Nexalin Technology, Inc. | 5.78 Million USD | -336.541% |
| PAVmed Inc | 64.82 Million USD | 61.069% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 50.589% |
| RxSight, Inc. | 103.85 Million USD | 75.698% |
| Sight Sciences, Inc. | 126.44 Million USD | 80.041% |
| SI-BONE, Inc. | 156.35 Million USD | 83.858% |
| TELA Bio, Inc. | 84.18 Million USD | 70.021% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 63.975% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 87.59% |
| LivaNova PLC | 843.54 Million USD | 97.008% |
| 908 Devices Inc. | 68.08 Million USD | 62.929% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 94.781% |
| Nemaura Medical Inc. | 7.13 Million USD | -253.533% |
| NeuroPace, Inc. | 75.29 Million USD | 66.482% |
| LENSAR, Inc. | 33.33 Million USD | 24.292% |
| Apyx Medical Corporation | 51.01 Million USD | 50.531% |
| Cutera, Inc. | 197.72 Million USD | 87.236% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -1.844% |
| BioSig Technologies, Inc. | 28.53 Million USD | 11.539% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 86.819% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 30.011% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 96.983% |
| Axonics, Inc. | 270.2 Million USD | 90.66% |
| Outset Medical, Inc. | 198.77 Million USD | 87.303% |
| IRIDEX Corporation | 31.81 Million USD | 20.67% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 85.996% |
| IRadimed Corporation | 30.12 Million USD | 16.216% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -195.804% |
| INVO Bioscience, Inc. | 7.85 Million USD | -221.368% |
| Telesis Bio, Inc. | 63.48 Million USD | 60.248% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 74.365% |
| Varex Imaging Corporation | 224.8 Million USD | 88.773% |
| Quipt Home Medical Corp. | 148.66 Million USD | 83.024% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -115.286% |
| Pulmonx Corporation | 112.68 Million USD | 77.603% |
| Dynatronics Corporation | 9.9 Million USD | -154.723% |
| Modular Medical, Inc. | 17.52 Million USD | -43.979% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -25.021% |
| Semler Scientific, Inc. | 38.94 Million USD | 35.194% |
| InMode Ltd. | 215.68 Million USD | 88.298% |
| Bruker Corporation | 1.07 Billion USD | 97.655% |
| Cytosorbents Corporation | 48.33 Million USD | 47.787% |
| DexCom, Inc. | 1.69 Billion USD | 98.508% |
| Align Technology, Inc. | 2.07 Billion USD | 98.785% |
| Viveve Medical, Inc. | 22.17 Million USD | -13.823% |
| ZimVie Inc. | 275.12 Million USD | 90.827% |
| Movano Inc. | 29.69 Million USD | 14.995% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 81.614% |
| Nexalin Technology, Inc. | 5.78 Million USD | -336.541% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -615.364% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 95.8% |
| Profound Medical Corp. | 33.6 Million USD | 24.894% |
| Insulet Corporation | 939.9 Million USD | 97.315% |
| Surmodics, Inc. | 98.69 Million USD | 74.429% |
| iCAD, Inc. | 22.22 Million USD | -13.557% |
| Nuwellis, Inc. | 22.61 Million USD | -11.608% |
| Biotricity, Inc. | 17.18 Million USD | -46.864% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 94.34% |
| Aethlon Medical, Inc. | 12.27 Million USD | -105.563% |
| InspireMD, Inc. | 22.95 Million USD | -9.969% |
| PAVmed Inc. | 64.82 Million USD | 61.069% |
| BIOLASE, Inc. | 34.66 Million USD | 27.186% |
| Beyond Air, Inc. | 61.7 Million USD | 59.096% |
| FONAR Corporation | 28.6 Million USD | 11.77% |
| AxoGen, Inc. | 149.33 Million USD | 83.1% |
| Vivani Medical, Inc. | 26.96 Million USD | 6.405% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 85.749% |
| Inari Medical, Inc. | 448.59 Million USD | 94.374% |
| UFP Technologies, Inc. | 58.08 Million USD | 56.553% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -412.176% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -299.444% |
| Tenon Medical, Inc. | 16.96 Million USD | -48.739% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -241.377% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 42.775% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.659% |
| Sintx Technologies, Inc. | 15.2 Million USD | -66.029% |
| NanoVibronix, Inc. | 4.97 Million USD | -407.501% |
| Quanterix Corporation | 118.1 Million USD | 78.63% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -115.286% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -74.754% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 93.573% |
| TransMedics Group, Inc. | 182.82 Million USD | 86.195% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 10.073% |
| NeuroMetrix, Inc. | 11.09 Million USD | -127.391% |
| Hyperfine, Inc. | 52.87 Million USD | 52.266% |
| Establishment Labs Holdings Inc. | 172 Million USD | 85.327% |
| Biomerica, Inc. | 6.97 Million USD | -261.68% |
| Bone Biologics Corporation | 9.42 Million USD | -167.683% |
| AVITA Medical, Inc. | 80.77 Million USD | 68.757% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -144.763% |
| Silk Road Medical, Inc | 186.35 Million USD | 86.457% |